Concepedia

Shiro Shibayama

SS

Statistics

Publications

21

Citations

1.5K

H-Index

15

Active since

2001

Affiliations

Ono Pharmaceutical (Japan)(Current)

Kumamoto University

University of Tsukuba

National Institutes of Health

Tokyo University of Science

Shiro Shibayama is an author at Ono Pharmaceutical (Japan) specializing in immunology, life sciences, and pharmacology.

Publications per year

2001–2021

21

Publications

21

IFN-α Directly Promotes Programmed Cell Death-1 Transcription and Limits the Duration of T Cell-Mediated Immunity

Seigo Terawaki, Shunsuke Chikuma, Shiro Shibayama et al. · The Journal of Immunology · 2011 · 337 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo

Shunsuke Chikuma, Seigo Terawaki, Tamon Hayashi et al. · The Journal of Immunology · 2009 · 242 citations

Life Sciences, Immunology, Pathology +14

Spirodiketopiperazine-Based CCR5 Inhibitor Which Preserves CC-Chemokine/CCR5 Interactions and Exerts Potent Activity against R5 Human Immunodeficiency Virus Type 1 In Vitro

Kenji Maeda, Hirotomo Nakata, Yasuhiro Koh et al. · Journal of Virology · 2004 · 221 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Novel Low Molecular Weight Spirodiketopiperazine Derivatives Potently Inhibit R5 HIV-1 Infection through Their Antagonistic Effects on CCR5

Kenji Maeda, Kazuhisa Yoshimura, Shiro Shibayama et al. · Journal of Biological Chemistry · 2001 · 126 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

TRIM28 prevents autoinflammatory T cell development in vivo

Shunsuke Chikuma, Naomasa Suita, Il‐mi Okazaki et al. · Nature Immunology · 2012 · 101 citations

Life Sciences, Cell Biology, Immunology +10

1–5 of 21